MSH2 and carcinoma: MSI analysis with the mononucleotide repeat markers BAT25 and BAT26 showed that all adenomas and carcinomas with absent MMR protein were microsatellite unstable with one exception, an adenoma with low-grade dysplasia from a MSH2 mutation carrier.